OMCL OMNICELL, INC.

Nasdaq omnicell.com


$ 29.69 $ 0.23 (0.78 %)    

Tuesday, 14-Oct-2025 15:59:59 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 29.69
$ 29.09
$ 29.00 x 5
$ 32.00 x 63
$ 29.08 - $ 29.74
$ 22.66 - $ 55.75
218,339
na
1.36B
$ 0.85
$ 59.07
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 10-30-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-02-2019 06-30-2019 10-Q
26 05-03-2019 03-31-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 11-02-2018 09-30-2018 10-Q
29 08-03-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-07-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 02-26-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-omnicell-lowers-price-target-to-55

Piper Sandler analyst Sean Wieland maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $57 t...

 wells-fargo-maintains-overweight-on-omnicell-raises-price-target-to-40

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and raises the price target from $37...

 wells-fargo-maintains-overweight-on-omnicell-raises-price-target-to-37

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and raises the price target from $35...

 b-of-a-securities-maintains-neutral-on-omnicell-raises-price-target-to-34

B of A Securities analyst Allen Lutz maintains Omnicell (NASDAQ:OMCL) with a Neutral and raises the price target from $30 to...

 omnicell-raises-fy2025-adj-eps-guidance-from-100-165-to-130-165-vs-162-est-affirms-fy2025-sales-guidance-of-110b-116b-vs-113b-est

Omnicell (NASDAQ:OMCL) raises FY2025 Adj EPS guidance from $1.00-$1.65 to $1.30-$1.65 vs $1.62 analyst estimate. Affirms FY2025...

 omnicell-raises-q2-adj-eps-guidance-from-019-032-to-024-034-vs-036-est-affirms-q2-sales-guidance-of-27000m-28000m-vs-27659m-est

Omnicell (NASDAQ:OMCL) raises Q2 Adj EPS guidance from $0.19-$0.32 to $0.24-$0.34 vs $0.36 analyst estimate. Affirms Q2 sales o...

 omnicell-board-approves-new-75m-stock-repurchase-program

Omnicell, Inc.'s (NASDAQ:OMCL) Board of Directors approved a new $75 million stock repurchase program (the "2025 Repurc...

 wells-fargo-upgrades-omnicell-to-overweight-raises-price-target-to-35

Wells Fargo analyst Stan Berenshteyn upgrades Omnicell (NASDAQ:OMCL) from Equal-Weight to Overweight and raises the price ta...

 benchmark-maintains-buy-on-omnicell-lowers-price-target-to-40

Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $62 to $40.

 wells-fargo-maintains-equal-weight-on-omnicell-lowers-price-target-to-31

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Equal-Weight and lowers the price target from $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION